Robecosam AG grew its position in shares of Silicon Laboratories (NASDAQ:SLAB) by 163.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 195,000 shares of the semiconductor company’s stock after purchasing an additional 121,000 shares during the quarter. Silicon Laboratories makes up 1.1% of Robecosam AG’s holdings, making the stock its 28th biggest holding. Robecosam AG owned approximately 0.46% of Silicon Laboratories worth $17,345,000 at the end of the most recent reporting period.
Several other hedge funds have also recently made changes to their positions in SLAB. Advisors Asset Management Inc. boosted its stake in shares of Silicon Laboratories by 75.1% during the third quarter. Advisors Asset Management Inc. now owns 1,292 shares of the semiconductor company’s stock valued at $103,000 after purchasing an additional 554 shares in the last quarter. Public Employees Retirement Association of Colorado acquired a new stake in shares of Silicon Laboratories during the fourth quarter valued at about $155,000. M&T Bank Corp acquired a new stake in shares of Silicon Laboratories during the fourth quarter valued at about $202,000. Amundi Pioneer Asset Management Inc. acquired a new stake in shares of Silicon Laboratories during the fourth quarter valued at about $203,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Silicon Laboratories by 52.7% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,479 shares of the semiconductor company’s stock valued at $219,000 after purchasing an additional 856 shares in the last quarter. 90.58% of the stock is currently owned by hedge funds and other institutional investors.
In other Silicon Laboratories news, SVP Brandon Tolany sold 18,235 shares of the business’s stock in a transaction that occurred on Monday, January 29th. The stock was sold at an average price of $95.00, for a total value of $1,732,325.00. Following the transaction, the senior vice president now directly owns 69,501 shares of the company’s stock, valued at $6,602,595. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director William G. Bock sold 2,500 shares of the business’s stock in a transaction that occurred on Thursday, February 15th. The shares were sold at an average price of $91.91, for a total value of $229,775.00. Following the completion of the transaction, the director now directly owns 40,926 shares in the company, valued at $3,761,508.66. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 29,926 shares of company stock worth $2,803,918. 1.96% of the stock is owned by insiders.
Silicon Laboratories (NASDAQ:SLAB) last posted its quarterly earnings data on Wednesday, January 31st. The semiconductor company reported $0.93 EPS for the quarter, topping the Zacks’ consensus estimate of $0.86 by $0.07. The company had revenue of $201.02 million for the quarter, compared to analyst estimates of $197.93 million. Silicon Laboratories had a return on equity of 11.11% and a net margin of 6.12%. The firm’s quarterly revenue was up 10.1% on a year-over-year basis. During the same period in the previous year, the firm earned $0.75 earnings per share. analysts predict that Silicon Laboratories will post 2.52 EPS for the current year.
A number of brokerages have recently commented on SLAB. Zacks Investment Research lowered Silicon Laboratories from a “hold” rating to a “sell” rating in a research note on Wednesday, February 7th. Needham & Company LLC reissued a “buy” rating and set a $115.00 price target (up from $110.00) on shares of Silicon Laboratories in a research note on Thursday, February 1st. Drexel Hamilton reissued a “buy” rating and set a $111.00 price target (up from $103.00) on shares of Silicon Laboratories in a research note on Wednesday, January 31st. Roth Capital lifted their price target on Silicon Laboratories from $105.00 to $110.00 and gave the company a “buy” rating in a research note on Tuesday, January 30th. Finally, B. Riley reissued a “buy” rating on shares of Silicon Laboratories in a research note on Monday, January 29th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and eight have issued a buy rating to the company. Silicon Laboratories has an average rating of “Buy” and a consensus price target of $102.89.
COPYRIGHT VIOLATION WARNING: “Robecosam AG Purchases 121,000 Shares of Silicon Laboratories (SLAB)” was reported by American Banking News and is the property of of American Banking News. If you are accessing this article on another publication, it was copied illegally and republished in violation of US and international copyright and trademark legislation. The legal version of this article can be viewed at https://www.americanbankingnews.com/2018/03/12/robecosam-ag-purchases-121000-shares-of-silicon-laboratories-slab.html.
About Silicon Laboratories
Silicon Laboratories Inc is a provider of silicon, software and solutions for the Internet of Things (IoT), Internet infrastructure, industrial, consumer and automotive markets. The Company operates through mixed-signal analog intensive products segment. It provides analog-intensive, mixed-signal solutions for use in a range of electronic products in various applications for the IoT market.
Receive News & Ratings for Silicon Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silicon Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.